The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
The anticoagulant activation of antithrombin by heparin
Open accessAbstract
Antithrombin, a plasma serpin, is relatively inactive as an inhibitor of the coagulation proteases until it binds to the heparan side chains that line the microvasculature. The binding specifically occurs to a core pentasaccharide present both in the heparans and in their therapeutic derivative heparin. The accompanying conformational change of antithrombin is revealed in a 2.9-Å structure of a dimer of latent and active antithrombins, each in complex with the high-affinity pentasaccharide. Inhibitory activation results from a shift in the main sheet of the molecule from a partially six-stranded to a five-stranded form, with extrusion of the reactive center loop to give a more exposed orientation. There is a tilting and elongation of helix D with the formation of a 2-turn helix P between the C and D helices. Concomitant conformational changes at the heparin binding site explain both the initial tight binding of antithrombin to the heparans and the subsequent release of the antithrombin–protease complex into the circulation. The pentasaccharide binds by hydrogen bonding of its sulfates and carboxylates to Arg-129 and Lys-125 in the D-helix, to Arg-46 and Arg-47 in the A-helix, to Lys-114 and Glu-113 in the P-helix, and to Lys-11 and Arg-13 in a cleft formed by the amino terminus. This clear definition of the binding site will provide a structural basis for developing heparin analogues that are more specific toward their intended target antithrombin and therefore less likely to exhibit side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
AMoRe: an automated package for molecular replacement
Navaza, J. (1994) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767393007597 · Cited by 4,953
Huber, R., & Carrell, R. W. (1989) · Biochemistry · doi:10.1021/bi00449a001 · Cited by 883
Self-citationAn efficient general-purpose least-squares refinement program for macromolecular structures
Tronrud, D. E., Ten Eyck, L. F., & Matthews, B. W. (1987) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767387099124 · Cited by 847
Loebermann, H., Tokuoka, R., Deisenhofer, J., & Huber, R. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90298-5 · Cited by 765
Choay, J., Petitou, M., Lormeau, J. C., Sinaÿ, P., Casu, B., & Gatti, G. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)90550-8 · Cited by 647
Self-citationOlson, S. T., Björk, I., Sheffer, R., Craig, P. A., Shore, J. D., & Choay, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42309-5 · Cited by 470
Further characterization of the antithrombin-binding sequence in heparin
Thunberg, L., Bäckström, G., & Lindahl, U. (1982) · Carbohydrate Research · doi:10.1016/s0008-6215(00)81050-2 · Cited by 455
Cited by
GLYCAM06: A generalizable biomolecular force field. Carbohydrates
Kirschner, K. N., Yongye, A. B., Tschampel, S. M., González‐Outeiriño, J., Daniels, C. R., Foley, B. L., & Woods, R. J. (2008) · Journal of Computational Chemistry · doi:10.1002/jcc.20820 · Cited by 2,243
Serpin Structure, Mechanism, and Function
Gettins, P. G. W. (2002) · Chemical Reviews · doi:10.1021/cr010170+ · Cited by 1,226
The Structure of Glycosaminoglycans and their Interactions with Proteins
Gandhi, N. S., & Mancera, R. L. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00741.x · Cited by 1,034
Demystifying Heparan Sulfate–Protein Interactions
Xu, D., & Esko, J. D. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035314 · Cited by 805
Roles of heparan-sulphate glycosaminoglycans in cancer
Sasisekharan, R., Shriver, Z., Venkataraman, G., & Narayanasami, U. (2002) · Nature Reviews Cancer · doi:10.1038/nrc842 · Cited by 621
Irving, J. A., Pike, R. N., Lesk, A. M., & Whisstock, J. C. (2000) · Genome Research · doi:10.1101/gr.147800 · Cited by 598
Self-citationA Synthetic Antithrombin III Binding Pentasaccharide Is Now a Drug! What Comes Next?
Petitou, M., & van Boeckel, C. A. A. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200300640 · Cited by 485
Self-citationStructural Insights into Biological Roles of Protein-Glycosaminoglycan Interactions
Raman, R., Sasisekharan, V., & Sasisekharan, R. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.11.020 · Cited by 434
Protein–polyelectrolyte interactions
Kayitmazer, A. B., Seeman, D., Minsky, B. B., Dubin, P. L., & Xu, Y. (2013) · Soft Matter · doi:10.1039/c2sm27002a · Cited by 406
Li, W., Johnson, D. J. D., Esmon, C. T., & Huntington, J. A. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb811 · Cited by 405
Interplay between platelets and coagulation
Sang, Y., Roest, M., de Laat, B., de Groot, P. G., & Huskens, D. (2021) · Blood Reviews · doi:10.1016/j.blre.2020.100733 · Cited by 405
Myocardial Extracellular Matrix: An Ever-Changing and Diverse Entity
Rienks, M., Papageorgiou, A.-P., Frangogiannis, N. G., & Heymans, S. (2014) · Circulation Research · doi:10.1161/circresaha.114.302533 · Cited by 366
Mycroft-West, C. J., Su, D., Pagani, I., Rudd, T. R., Elli, S., Gandhi, N. S., Guimond, S. E., Miller, G. J., Meneghetti, M. C. Z., Nader, H. B., et al. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1721319 · Cited by 361
Pharmacology of Heparin and Related Drugs
Mulloy, B., Hogwood, J., Gray, E., Lever, R., & Page, C. P. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011247 · Cited by 341
Serpin structure, function and dysfunction
HUNTINGTON, J. A. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04360.x · Cited by 330
Synthesis of thrombin-inhibiting heparin mimetics without side effects
Petitou, M., Hérault, J.-P., Bernat, A., Driguez, P.-A., Duchaussoy, P., Lormeau, J.-C., & Herbert, J.-M. (1999) · Nature · doi:10.1038/18877 · Cited by 326
Self-citationHeparin and heparan sulfate: biosynthesis, structure and function
Sasisekharan, R. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00145-9 · Cited by 326
Heparan sulfate: growth control with a restricted sequence menu
Gallagher, J. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13713 · Cited by 319
Conformation and dynamics of heparin and heparan sulfate
Mulloy, B., & Forster, M. J. (2000) · Glycobiology · doi:10.1093/glycob/10.11.1147 · Cited by 315
GLYCOMICS APPROACH TO STRUCTURE-FUNCTION RELATIONSHIPS OF GLYCOSAMINOGLYCANS
Sasisekharan, R., Raman, R., & Prabhakar, V. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095745 · Cited by 278
Chapter 3 Interactions Between Heparan Sulfate and Proteins—Design and Functional Implications
(2009) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(09)76003-4 · Cited by 274
Conformational Pathology of the Serpins: Themes, Variations, and Therapeutic Strategies
Gooptu, B., & Lomas, D. A. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082107.133320 · Cited by 261
Cheng, H., Cao, X., Zhang, S., Zhang, K., Cheng, Y., Wang, J., Zhao, J., Zhou, L., Liang, X., & Yoon, J. (2023) · Advanced Materials · doi:10.1002/adma.202207546 · Cited by 260
Searching for Alternatives to Heparin Sulfated Fucans from Marine Invertebrates
Mourão, P. (1999) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00032-3 · Cited by 174
Marie, A.-L., Dominguez-Vega, E., Saller, F., Plantier, J.-L., Urbain, R., Borgel, D., Tran, N. T., Somsen, G. W., & Taverna, M. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.10.016 · Cited by 26
Capila, I., & Linhardt, R. J. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020201)41:3<390::aid-anie390>3.0.co;2-b
Metadata
- Authors
- Jin, L., Abrahams, J. P., Skinner, R., Petitou, M., Pike, R. N., & Carrell, R. W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-12-23
- Volume
- 94
- Issue
- 26
- Pages
- 14683-14688
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2001790577
- Cited by
- 685
- References
- 20
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.